Notice
19 Sep 2025
d-amphetamine, lisdexamfetamine, production quota, drug enforcement, dea, pharmaceuticals, manufacturing
💊DEA Adjusts Production Quota for Lisdexamfetamine and d-Amphetamine
The Drug Enforcement Administration (DEA) is adjusting the 2025 aggregate production quota for the schedule II controlled substances lisdexamfetamine and d-amphetamine (for conversion). In making this determination, DEA has considered the factors set forth in 21 CFR 1303.13(b) in accordance with 21 U.S.C. 826(a) and is expediting publication of this determination to comply with the timeframes specified in 21 U.S.C. 826(h)(1).
Learn More